Perspective Therapeutics (CATX) Equity Income (2023 - 2025)
Perspective Therapeutics recorded quarterly Equity Income of -$1000.0 in Q4 2025, little changed quarter-over-quarter from -$1000.0 in Q1 2025, and up 50.0% year-over-year from -$666.67 in Q4 2024.
Perspective Therapeutics' Equity Income history runs 3 years deep, the most recent figure standing at -$1000.0 for Q4 2025.
- In Q4 2025, Equity Income rose 50.0% year-over-year to -$1000.0; the TTM figure through Mar 2026 stood at -$1000.0 (up 85.71% YoY), while the FY2025 annual figure was -$2000.0, up 75.0% from the prior year.
- Equity Income came in at -$1000.0 for Q4 2025 at Perspective Therapeutics, roughly flat from -$1000.0 in the prior quarter.
- In the past five years, Equity Income ranged from a high of -$1000.0 in Q1 2025 to a low of -$12000.0 in Q3 2023.
- A 3-year average of -$3857.1 and a median of -$2000.0 in 2024 frame the typical range for Equity Income.
- Across the five-year window, Equity Income jumped 60.0% in 2024 and surged 50.0% in 2025, its largest moves.
- Perspective Therapeutics' Equity Income stood at -$5000.0 in 2023, then surged by 60.0% to -$2000.0 in 2024, then soared by 50.0% to -$1000.0 in 2025.
- According to Business Quant data, Equity Income over the past three periods registered -$1000.0, -$1000.0, and -$2000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -5,000.00 |
| Sep 30, 2023 | -12,000.00 |